Literature DB >> 22393190

Ten years of progress in non-small cell lung cancer.

David S Ettinger1.   

Abstract

Entities:  

Mesh：

Year:  2012        PMID： 22393190     DOI： 10.6004/jnccn.2012.0029

Source DB:  PubMed          Journal:  J Natl Compr Canc Netw        ISSN： 1540-1405            Impact factor:   11.908


× No keyword cloud information.
  25 in total

1.  Interdisciplinary Palliative Care for Patients With Lung Cancer.

Authors:  Betty Ferrell; Virginia Sun; Arti Hurria; Mihaela Cristea; Dan J Raz; Jae Y Kim; Karen Reckamp; Anna Cathy Williams; Tami Borneman; Gwen Uman; Marianna Koczywas
Journal:  J Pain Symptom Manage       Date:  2015-08-19       Impact factor: 3.612

2.  Epidermal growth factor receptor exon 20 mutation increased in post-chemotherapy patients with non-small cell lung cancer detected with patients' blood samples.

Authors:  Ying Wang; Wenlong Bao; Hua Shi; Chuming Jiang; Yongjun Zhang
Journal:  Transl Oncol       Date:  2013-08-01       Impact factor: 4.243

3.  Expression of fibroblast growth factor receptor 1, fibroblast growth factor 2, phosphatidyl inositol 3 phosphate kinase and their clinical and prognostic significance in early and advanced stage of squamous cell carcinoma of the lung.

Authors:  Cigdem Usul Afsar; Berksoy Sahin; Meral Gunaldi; Emine Kılıc Bagir; Derya Gumurdulu; Refik Burgut; Melek Erkisi; Ismail Oguz Kara; Semra Paydas; Feryal Karaca; Vehbi Ercolak
Journal:  Int J Clin Exp Pathol       Date:  2015-09-01

4.  Early Candidate Biomarkers of Non-Small Cell Lung Cancer Are Screened and Identified in Premalignant Lung Lesions.

Authors:  Yandong Nan; Jie Du; Lijie Ma; Hua Jiang; Faguang Jin; Shuanying Yang
Journal:  Technol Cancer Res Treat       Date:  2016-07-08

5.  Support for Patients and Family Caregivers in Lung Cancer: Educational Components of an Interdisciplinary Palliative Care Intervention.

Authors:  Tami Borneman; Virginia Sun; Anna Cathy Williams; Rebecca Fujinami; Catherine Del Ferraro; Peggy S Burhenn; Terry Irish; Finly Zachariah; Carin van Zyl; Sorin Buga
Journal:  J Hosp Palliat Nurs       Date:  2015-08       Impact factor: 1.918

Review 6.  Re-Treatment with EGFR-TKIs in NSCLC Patients Who Developed Acquired Resistance.

Authors:  Wen-Shuo Wu; Yuh-Min Chen
Journal:  J Pers Med       Date:  2014-06-25

7.  Diabetes Insipidus: An Unusual Presentation of Adenocarcinoma of the Lung in a Patient with no Identifiable Lung Mass.

Authors:  Shuchi Gulati; Christoper Kiefer; Nagla Abdel Karim
Journal:  N Am J Med Sci       Date:  2015-10

8.  Diagnostic value of signal peptide-Complement C1r/C1s, Uegf, and Bmp1-epidermal growth factor domain-containing protein 1 on serum and tissue samples in non-small cell lung cancer.

Authors:  Selçuk Gürz; Burçin Çelik; Ahmet Menteşe; Diler Us Altay
Journal:  Turk Gogus Kalp Damar Cerrahisi Derg       Date:  2018-04-30       Impact factor: 0.332

9.  MCTS1 promotes the development of lung adenocarcinoma by regulating E2F1 expression.

Authors:  Cun Gao; Rui Dong; Yongmeng Li; Jinghui Liang; Hui Tian
Journal:  Oncol Lett       Date:  2021-05-17       Impact factor: 2.967

10.  The prognostic value of USP14 and PSMD14 expression in non-small cell lung cancer.

Authors:  Jian Lei; Xiaoliu Liu; Wei Liu; Yun Zhang; Zhihong Liu
Journal:  Ann Transl Med       Date:  2021-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.